BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 7588252)

  • 1. The effect of naloxone administration on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin in unperturbed horses.
    Alexander SL; Irvine CH
    Endocrinology; 1995 Nov; 136(11):5139-47. PubMed ID: 7588252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The acute effect of lowering plasma cortisol on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin as revealed by intensive sampling of pituitary venous blood in the normal horse.
    Alexander SL; Irvine CH; Livesey JH; Donald RA
    Endocrinology; 1993 Aug; 133(2):860-6. PubMed ID: 8393777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of the regulation of the hypothalamo-pituitary-adrenal (HPA) axis determined using a nonsurgical method for collecting pituitary venous blood from horses.
    Alexander SL; Irvine CH; Donald RA
    Front Neuroendocrinol; 1996 Jan; 17(1):1-50. PubMed ID: 8788568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of acute exercise on the secretion of corticotropin-releasing factor, arginine vasopressin, and adrenocorticotropin as measured in pituitary venous blood from the horse.
    Alexander SL; Irvine CH; Ellis MJ; Donald RA
    Endocrinology; 1991 Jan; 128(1):65-72. PubMed ID: 1846116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of cortisol, vasopressin (AVP), and corticotropin-releasing factor administration on pulsatile adrenocorticotropin, alpha-melanocyte-stimulating hormone, and AVP secretion in the pituitary venous effluent of the horse.
    Livesey JH; Donald RA; Irvine CH; Redekopp C; Alexander SL
    Endocrinology; 1988 Aug; 123(2):713-20. PubMed ID: 2840266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term secretion patterns of corticotropin-releasing hormone, arginine vasopressin and ACTH as shown by intensive sampling of pituitary venous blood from horses.
    Alexander SL; Irvine CH; Donald RA
    Neuroendocrinology; 1994 Sep; 60(3):225-36. PubMed ID: 7969780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the alpha-2-adrenergic agonist, clonidine, on secretion patterns and rates of adrenocorticotropic hormone and its secretagogues in the horse.
    Alexander SL; Irvine CH
    J Neuroendocrinol; 2000 Sep; 12(9):874-80. PubMed ID: 10971812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated basal adrenocorticotropin and evidence for increased central opioid tone in highly trained male athletes.
    Inder WJ; Hellemans J; Ellis MJ; Evans MJ; Livesey JH; Donald RA
    J Clin Endocrinol Metab; 1995 Jan; 80(1):244-8. PubMed ID: 7829620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
    Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
    J Clin Endocrinol Metab; 1994 Jul; 79(1):140-4. PubMed ID: 8027217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inferior petrosal sinus sampling in healthy subjects reveals a unilateral corticotropin-releasing hormone-induced arginine vasopressin release associated with ipsilateral adrenocorticotropin secretion.
    Kalogeras KT; Nieman LK; Friedman TC; Doppman JL; Cutler GB; Chrousos GP; Wilder RL; Gold PW; Yanovski JA
    J Clin Invest; 1996 May; 97(9):2045-50. PubMed ID: 8621793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of an osmotic stimulus on the secretion of arginine vasopressin and adrenocorticotropin in the horse.
    Irvine CH; Alexander SL; Donald RA
    Endocrinology; 1989 Jun; 124(6):3102-8. PubMed ID: 2542009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of saline-induced changes in vasopressin secretion to basal and corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol secretion in man.
    Rittmaster RS; Cutler GB; Gold PW; Brandon DD; Tomai T; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1987 Feb; 64(2):371-6. PubMed ID: 3025246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The luteinizing hormone but not the cortisol response to arginine vasopressin is prevented by naloxone and a corticotropin-releasing hormone antagonist in the ovariectomized rhesus monkey.
    Xiao E; Xia-Zhang L; Thornell D; Shalts E; Ferin M
    Neuroendocrinology; 1996 Sep; 64(3):225-32. PubMed ID: 8875440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 potentiates basal and AVP-stimulated ACTH secretion in vitro--the role of CRH pre-incubation.
    Prickett TCR ; Inder WJ; Evans MJ; Donald RA
    Horm Metab Res; 2000 Sep; 32(9):350-4. PubMed ID: 11014382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of insulin-induced hypoglycaemia on secretion patterns and rates of corticotrophin-releasing hormone, arginine vasopressin and adrenocorticotrophin in horses.
    Alexander SL; Roud HK; Irvine CH
    J Endocrinol; 1997 Jun; 153(3):401-9. PubMed ID: 9203994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic challenge with endotoxin stimulates corticotropin-releasing hormone and arginine vasopressin secretion into hypophyseal portal blood: coincidence with gonadotropin-releasing hormone suppression.
    Battaglia DF; Brown ME; Krasa HB; Thrun LA; ViguiƩ C; Karsch FJ
    Endocrinology; 1998 Oct; 139(10):4175-81. PubMed ID: 9751497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A synergistic adrenocorticotropin response to naloxone and vasopressin in normal humans: evidence that naloxone stimulates endogenous corticotropin-releasing hormone.
    Hockings GI; Grice JE; Walters MM; Crosbie GV; Torpy DJ; Jackson RV
    Neuroendocrinology; 1995 Feb; 61(2):198-206. PubMed ID: 7753339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
    Arvat E; Maccagno B; Ramunni J; Di Vito L; Broglio F; Deghenghi R; Camanni F; Ghigo E
    Neuroendocrinology; 1997 Dec; 66(6):432-8. PubMed ID: 9430449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia.
    Engler D; Pham T; Fullerton MJ; Ooi G; Funder JW; Clarke IJ
    Neuroendocrinology; 1989 Apr; 49(4):367-81. PubMed ID: 2541360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.